ABSTRACT. The effect of Cis-platin on the glomerular data substantiating this statement are scarce. In the present study filtration rate and effective renal plasma flow was deter-we compared, GFR and ERPF of young and adult rats after mined using a radioisotope clearance technique in young (3 various doses of Cis-platin. We also evaluated the renal handling wk old) and adult (more than 12 wk old) rats. Cis-platin of this drug by measuring urinary excretion and renal accumuwas administered intravenously in dosages ranging from lation of Pt.
~~~~l f~~~t i~~ determination. ~h~ GFR and the ERPF were days after Cis-platin administration, up to 60% of the determined by a plasma clearance technique, as described in amount of ~latinum injected was excreted in the urine of detail elsewhere (12) . This method involves iv injection of Cr-5 1 both age groups. There was a marked difference, however, EDTA and 1-125 Iodohippurate (Amersham International, in renal platinum concentration between the two groups-In Amenham, England) and a single timed blood sample collected young rats renal platinum concentration was only 63 and 60 min after the injection. The method allows for repeated use 49% of that in adult rats after 5 and 7.5 mg/kg body in the same animal.
weight, respectively. We believe that this is due to the pt determination. The Pt content of urine and renal tissue was comparatively larger renal mass in relation to body weight determined by atomic absorption spectrophotometry a in the young animals. Relatively more renal tissue provides Perkin Elmer 2380 spectrophotometer. The urine samples were at least partial protection against nephrotoxic drugs in analyzed without pretreatment and read against a standard curve these young rats. (Pediatr Res 20: [9] [10] [11] [12] [13] [14] 1986) based on aqueous standards. The kidneys were weighed, freeze dried, and digested in 65% HN03 at 200" C in 1.5-2 h. PtAbbreviations standards were added to control kidneys which were similarly treated. The dry residue was then dissolved in 2 ml of distilled BW, body weight water, and analyzed. ERPF, effective renal plasma flow Experimental Protocol. Single dosage regimen. Cis-platin GFR, glomerular filtration rate (kindly supplied by Bristol Meyers BV, Weesp, The Netherlands) iv, intravenous was diluted with distilled water to a final concentration of 1 mg Pi, platinum Cis-platin, 9 mg NaCl, and 10 mg mannitol per ml. Cis-platin was administered iv in a dose of 2.5, 5, or 7.5 mg/ kg BW in adult rats and 5, 7.5, or 10 mg/kg BW in the young animals. The highest dose was determined by the 100% mortality Cis-platin (Cis-diamminedichloroplatinum, abbreviated as rate for both age groups. Control animals were given iv injections CDDP) has been proven to be a valuable agent in adult oncologic of distilled water. At the start of the experiments the groups therapy and is increasingly used in pediatric oncology (1-3). consisted of five to 15 rats. Animal (4, 5) as well as clinical (6) (7) (8) studies have demonstrated Renal function was determined 4, 7, 14, 21, 42, and 105 days that therapeutic dosage leads to nephrotoxicity. This side effect after drug administration. may in fact be dose limiting (4, 9) . The nephrotoxicity can be Fractionated dose regimen. In this regimen the total amount alleviated but not entirely prevented by good hydration, forced of Cis-platin was administered iv in equal doses over 5 successive diuresis, and prolonged administration (7, 8, 10) .
days. The total dosage was the same for adult and young rats, It has been suggested that the incidence of nephrotoxicity in viz 5 x 1, 5 x 1.5, or 5 x 2 mg/kg BW. Control animals were children is less than in adults (1 1). Clinical and experimental given 5 daily iv injections of distilled water. At the start of the experiment the groups consisted of five to 10 rats. Young rats. The young rats failed to grow during the first days after drug administration but resumed gaining weight after 1 wk.
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As a result dose-dependent differences in BW were observed and * remained statistically different up to the 6th wk (Table 2) . Young rats treated with 10 mg/kg BW all died in the 1st wk following
administration. When expressed in ml/min the GFR was signif-
2
icantly less in young rats treated with Cis-platin than in controls. .=:
As both GFR and BW were reduced, the GFR per 100 g BW $ showed little difference in rats treated with 5 or 7.5 mg/kg BW . swhen compared to the control rats. E the fall in GFR was less in the young rats than in the adult ones.
%
This was true not only when the GFR was related to BW (ml/ -; min/ 100 g BW) (Fig. I ) but also when absolute values (ml/min) were taken into consideration (Tables I and 2 ). Furthermore, renal function remained permanently reduced in the adult rats, while there was complete recovery in the young ones. Fractionated Dosage Regimen. Adult rats. The weight loss observed during the first 2 wk after drug administration was comparable with the weight loss after corresponding single doses. However, fractionation did reduce the mortality rate and immediate nephrotoxicity (Table 3 ). All animals survived after 5 X 1.5 mg/kg BW, while only 50% died during the first 3 wk after a dose of 5 x 2 mg/kg BW. The initial impairment in renal function was less severe after 5 x 1 mg/kg BW than after 1 x 5 mg/kg BW. However, at the end of the 15 wk follow-up period the renal impairment was similar after either dosage regimens. Young rats. Fractionation caused a growth retardation similar to that observed after a single dose when 5 mg/kg BW was administered. With 7.5 mg/kg BW, the growth reduction was less when given fractionated than after a single dose (Tables 2  and 4 ). The GFR (ml/min) of rats treated with Cis-platin was less than that of controls. However, the GFR relative to body weight (ml/min/100 g) showed little difference from control values. After fractionated dosage of Cis-platin the GFR was generally comparable to the GFR after an identical single dose.
Comparison between Young and Adult Rats. In the young rats, renal function was less affected by the same dose of Cis-platin given fractionated than in adult animals. The GFR per 100 g BW, as percentage of the mean value in controls, was determined on day 4 after drug administration and is plotted against the total dose of Cis-platin. As shown in Figure 1 , the dose response curve for the adult rats is much steeper than for young rats. This difference remained at the end of the 15 wk follow-up period (Fig. 2) .
Renal Pt Handlin~. During the first 2 days after a single dose of 5 mg Cis-platin per kg BW about 60%-of the administered amount of Pt was excreted in the urine of young as well as adult rats. After 7.5 mg Cis-platin per kg BW the young rats excreted relatively more Pt than the adult rats ( Table 5 ). Most of the Pt was excreted during the 1 st day after administration. After 2 days both Cis-platin doses caused a similar Pt accumulation in young and adult rats of 1.5-2% of the injected amount of Pt. However, the renal Pt concentration was significantly lower in the young rats compared to the adult rats (Table 5 ). This was due to the larger renal mass relative to BW in the young rats. As shown in Table 5 the wet kidney weight per 100 g BW of young rats was 179 and 165% of that of adult rats in the 5 and 7.5 mg dose group, respectively.
DISCUSSION
Our study has shown that an identical dose of Cis-platin per kg BW administered to either young or adult rats, leads to a deterioration of renal function which is comparatively less severe in young rats. In both young and adult rats the deterioration in renal function occurs during the initial days after Cis-platin administration with gradual recovery during the following weeks. Complete recovery is more likely to occur in young rats with a higher degree of permanent damage in adult rats. In young rats Cis-platin temporarily arrests body growth and renal development, but this does not affect the potential for growth and development. The initial impairment in renal function of young rats is almost proportionate to the retardation in growth. While the absolute GFR (ml/min) of young rats under treatment dropped well below that of controls, the GFR in relation to BW only fell below control values when the highest dose of Cis-platin was administered. Fractionated dosage reduced the initial renal damage in the adult rats, allowing for higher doses. Fractionation did not have that effect on the young animals, while it had hardly any effect on the permanent renal damage in either age group. Apart from changes in renal function, both young and adult rats suffered from gastrointestinal toxicity immediately on drug administration. The animals became anorectic and particularly the higher dosage led to hemorrhagic diarrhea. It is not clear to what extent gastrointestinal toxicity and the resultant dehydration contributes to the deterioration in renal function and subsequent mortality in young rats. In the young rats the gastrointestinal complications rather than renal failure seemed to play a major part in the acute morbidity and mortality.
The nephrotoxicity of Cis-platin has been subject to extensive study, (4, 5, 7, 8, 13, 14) ; the exact mechanism is not yet clear. The morphologic, biochemical, and functional disarrangement is rather unspecific, and has also been observed after heavy metal poisoning (7, 15) . Morphologically, renal damage is largely confined to the pars recta of the proximal tubule (4) (5) (6) 16) . Despite the tubular location of the renal damage, the GFR still seems to be a rather sensitive parameter to quantitate the nephrotoxicity (14) . It cannot be excluded, however, that the measured GFR in fact underestimates the actual GFR, because of tubular backleak of the marker isotope (16) . The decrease in GFR has also been attributed to the vasoconstriction of renal vessels by an activation of the renin-angiotensin system (7) . Such an activation may be a direct effect of Cis-platin or function indirectly as a protective feedback mechanism, secondary to the excessive salt and fluid losses.
The difference in nephrotoxicity of Cis-platin in either young or adult rats is based on the difference in renal Pt concentration.
Our analysis of the renal handling of Pt indicated that there was hardly any difference in the renal accumulation of Pt when comparing young and adult rats. Renal Pt excretion was also the same in young and adult rats after a dose of 5 mg/kg BW. After 7.5 mg/kg BW, the urinary Pt excretion was less efficient in the adult rats compared to the young rats. This might be due to the severe decline in renal function in the adult rats. The concentration of Pt in renal tissue, however, was significantly lower in young rats than in adult ones. This difference is due to the larger amount of renal tissue in relation to BW in the young rats (12) . The magnitude of the Pt levels in renal tissue measured by us are comparable to those reported by others (9, 17) . If Cis-platin nephrotoxicity is related to the Pt concentration in the kidney, the lower Pt levels found in the kidneys of young rats provide an explanation for the attenuated nephrotoxicity observed in these animals.
An attenuated nephrotoxicity in young rats is not a unique finding for Cis-platin. Similar results have been obtained comparing the nephrotoxicity of the aminoglycosides gentamicin and amikacin in young and adult rats. Both compounds when administered in dosages relative to BW were found to be less nephrotoxic in young rats. At the same time, despite a similar renal uptake, tissue aminoglycoside concentrations were found to be lower in these rats (18) . Consequently, we surmised that drug-induced nephrotoxicity will generally be less in young than in adult rats, due to the larger amount of renal tissue relative to BW. In this respect it may be of importance that in humans, kidney weight relative to BW decreases with age (19) .
In conclusion, when Cis-platin is administered in doses relative to BW this drug is less nephrotoxic in young rats than in adult rats. This reduction in nephrotoxicity is the result of the comparatively larger amount of renal tissue relative to body weight present in young rats. 
